RedHill Biopharma (RDHL) EV to EBIT (2014 - 2021)
RedHill Biopharma's EV to EBIT was 2193.90 in the quarter ended Sep 30, 2021, down 66.1% from 6466.09 a year earlier and down 35.9% from the prior quarter.
RedHill Biopharma (RDHL) EV to EBIT (2014 - 2021) Analysis & Trends
On a trailing twelve-month basis, RedHill Biopharma's EV to EBIT was 2191.60 through Sep 30, 2021, down 66.1% year-over-year; for the year ended Dec 31, 2020, it came in at 4871.36, down 1.7% from the prior year.
- In earlier years, EV to EBIT was 4954.67 in the year ended Dec 31, 2019 (+51.9%), 3261.57 in the year ended Dec 31, 2018 (+86.9%), 1745.07 in the year ended Dec 31, 2017 (-60.3%) and 4399.43 in the year ended Dec 31, 2016 (-40.9%).
- The figure for the quarter ended Sep 30, 2021 marks the lowest quarterly EV to EBIT since the quarter ended Mar 31, 2018.
- Compared with a year earlier, EV to EBIT was higher in four of the last eight quarters, with growth averaging 6.4%.
- The best year-over-year quarter for EV to EBIT over five years was the quarter ended Mar 31, 2019 (growth of 184.3%); the worst was the quarter ended Sep 30, 2021 (a decline of 66.1%).
- Per Business Quant data, RDHL's EV to EBIT in the three quarters before the quarter ended Sep 30, 2021 was 3420.72 (quarter ended Jun 30, 2021), 4335.06 (quarter ended Mar 31, 2021) and 4871.36 (quarter ended Dec 31, 2020).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | RedHill Biopharma | 7.53 Mn | 7.53 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2021 | 2,193.90 |
| Jun 30, 2021 | 3,420.72 |
| Mar 31, 2021 | 4,335.06 |
| Dec 31, 2020 | 4,871.36 |
| Sep 30, 2020 | 6,466.09 |
| Jun 30, 2020 | 4,620.50 |
| Mar 31, 2020 | 3,130.78 |
| Dec 31, 2019 | 4,954.67 |
| Sep 30, 2019 | 3,923.22 |
| Jun 30, 2019 | 3,631.54 |
| Mar 31, 2019 | 4,983.15 |
| Dec 31, 2018 | 3,261.57 |
| Sep 30, 2018 | 3,571.09 |
| Jun 30, 2018 | 3,145.11 |
| Mar 31, 2018 | 1,752.79 |
| Dec 31, 2017 | 1,745.79 |
| Sep 30, 2017 | 2,979.99 |
| Jun 30, 2017 | 2,694.52 |
| Mar 31, 2017 | 3,545.44 |
| Dec 31, 2016 | 4,399.43 |
RedHill Biopharma EV to EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=RDHL&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebit", "ticker": "RDHL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=RDHL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();